Pharmacoepidemiology

863 publications in "Pharmacoepidemiology"

Feb-13

The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population- based cohort

Pharmacoepidemiology Respiratory

Read more

Feb-13

Diuretic initiation and the acute risk of hip fracture

Musculoskeletal Pharmacoepidemiology

Read more

Jan-13

A new “Comparative Effectiveness” assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazone

Cardiovascular Pharmacoepidemiology

Read more

Dec-12

COPD and risk of lung cancer: The importance of smoking and timing of diagnosis of COPD

Oncology Pharmacoepidemiology Respiratory Smoking

Read more

Dec-12

Antiepileptic drugs during pregnancy in primary care: a UK population based study

Gynecology and Obstetrics Neurology Pharmacoepidemiology Women's Health

Read more

Dec-12

Impact of Age, Sex, Obesity, and Steroid Use on Quinolone-associated Tendon Disorders

General Analysis Pharmacoepidemiology Rheumatology

Read more

Dec-12

Children at risk of medicinal and non-medicinal poisoning: a population-based case-control study in general practice

Paediatrics Pharmacoepidemiology

Read more

Dec-12

Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence

Mental Health Neurology Paediatrics Pharmacoepidemiology

Read more

Nov-12

Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

Pharmacoepidemiology

Read more

Oct-12

Characteristics of Initiators of Different Osteoporosis (OP) Medications among Women with Postmenopausal Osteoporosis (PMO) in The Health Improvement Network (THIN) in the UK

Gynecology and Obstetrics Musculoskeletal Pharmacoepidemiology Women's Health

Read more

Oct-12

Prescribing Pattern of Glucose Lowering Drugs in the UK in the Last Decade: Focus on the Warnings About Rosiglitazone

Pharmacoepidemiology

Read more

Oct-12

Intermittent Nitrate Use and Risk of Hip Fracture

Musculoskeletal Pharmacoepidemiology

Read more
Date Title Categories
Feb-13 The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population- based cohort

Pharmacoepidemiology Respiratory

Feb-13 Diuretic initiation and the acute risk of hip fracture

Musculoskeletal Pharmacoepidemiology

Jan-13 A new “Comparative Effectiveness” assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazone

Cardiovascular Pharmacoepidemiology

Dec-12 COPD and risk of lung cancer: The importance of smoking and timing of diagnosis of COPD

Oncology Pharmacoepidemiology Respiratory Smoking

Dec-12 Antiepileptic drugs during pregnancy in primary care: a UK population based study

Gynecology and Obstetrics Neurology Pharmacoepidemiology Women's Health

Dec-12 Impact of Age, Sex, Obesity, and Steroid Use on Quinolone-associated Tendon Disorders

General Analysis Pharmacoepidemiology Rheumatology

Dec-12 Children at risk of medicinal and non-medicinal poisoning: a population-based case-control study in general practice

Paediatrics Pharmacoepidemiology

Dec-12 Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence

Mental Health Neurology Paediatrics Pharmacoepidemiology

Nov-12 Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

Pharmacoepidemiology

Oct-12 Characteristics of Initiators of Different Osteoporosis (OP) Medications among Women with Postmenopausal Osteoporosis (PMO) in The Health Improvement Network (THIN) in the UK

Gynecology and Obstetrics Musculoskeletal Pharmacoepidemiology Women's Health

Oct-12 Prescribing Pattern of Glucose Lowering Drugs in the UK in the Last Decade: Focus on the Warnings About Rosiglitazone

Pharmacoepidemiology

Oct-12 Intermittent Nitrate Use and Risk of Hip Fracture

Musculoskeletal Pharmacoepidemiology

1 49 50 51 52 53 72